Skip to content

comparison of clinical efficacy of PE-TLIF and MIS-TLIF in the treatment of single level lumbar degenerative disease

the anatomy and clinical efficacy study of PE-TLIF based on 3D-DESS imaging

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073788
Enrollment
Unknown
Registered
2023-07-20
Start date
2023-07-14
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar degenerative disease

Interventions

Experimental group:Patient undergoes PE-TLIF surgery
Control Group:Patient undergoes MIS-TLIF surgery

Sponsors

Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) The subjects are aged between 40 and 70 years old (including 40 and 70 years old), regardless of gender; 2) Clinical symptoms include severe back pain or leg pain, with or without intermittent claudication; 3) After 3-6 months of strict Conservative management, it was ineffective; 4) The imaging findings were single level lumbar spondylolisthesis (?~? degrees), lumbar spinal canal stenosis, and lumbar disc herniation, which were consistent with the clinical symptoms. 5) No mental illness, able to tolerate surgery and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1) Those diagnosed with multi-segment lumbar spine lesions based on symptoms, signs, and imaging examination; 2) Patients with a history of mental illness; 3) Patients with a history of lumbar spine surgery; 4) Patients with severe osteoporosis (T-value measured by dual energy X-ray absorption method = 2.5); 5) Patients with clear surgical Contraindication, such as severe heart disease, diabetes, renal failure, Respiratory failure, coagulation disorders and other serious medical diseases; 6) Patients who refuse to sign informed consent forms

Design outcomes

Primary

MeasureTime frame
interbody fusion rate;JOA;

Secondary

MeasureTime frame
ODI;Internal fixation failure rate;VAS;

Countries

China

Contacts

Public ContactHaijun Li

Taizhou People's Hospital

13901436563@163.com+86 139 0143 6563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026